Equine fetal post-mortem guidelines for veterinarians
Around 5% of Thoroughbred mares in Australia lose their pregnancies each year, resulting in significant welfare, environmental and economic impacts across the Thoroughbred industry. These...
THOROUGHBRED HORSES
45 pages
Published: 1 Sep 2005
Author(s): Whalley, J M
Download report PDF
DownloadPurchase a hard copy - AUD $45.00
This report describes development towards potential new vaccines for EHV-1. Firstly the immunogenicity of a formulation containing EHV-1 envelope glycoproteins was tested by measuring antibody responses of mares and young foals. Secondly, in order to provide a system whereby these and other vaccines could be assessed, an experimental EHV-1 respiratory challenge model of infection was established in mares and foals, using an Australian isolate of EHV-1. This model was then used to determine whether the immune responses to the glycoprotein formulation could provide protection against EHV-1 infection.